MedPath

Comparison of Quality of Life and Functionnal Resultats After Sigmodectomy Between Diverticulitis and Cancer

Conditions
Sigmoid Cancer
Sigmoid Diverticulosis
Interventions
Procedure: Sigmoidectomy
Registration Number
NCT04729283
Lead Sponsor
Nantes University Hospital
Brief Summary

The aim of this present study is to compare functional results and quality of life after sigmoidectomy for diverticulitis and sigmoid cancer.

Detailed Description

Rectal resection surgery can lead to numerous complications in term of gastrointestinal results with onset of fecal incontinence or in contrast constipation, and in term of genitourinary results with occurrence of dysuria, erectile dysfunction, or vaginal dryness. The low anterior resection syndrome is defined by the occurrence after rectal resection, of gastrointestinal symptoms like fecal incontinence or stool evacuation difficulties, which affect quality of life, despite conservation of anal sphincter. This syndrome is now well known and used in many countries.

However, there is a lack of data concerning gastrointestinal functional results after sigmoid surgery whether it is for cancer or diverticulitis. Some studies highlighted symptoms persistence in many patients after sigmoidectomy. Lately, the LARS score was used after sigmoidectomy for cancer. This study reveals symptoms of low anterior resection syndrome for 41 % of patients. The correlation between rectal resection and sigmoidectomy could be explain by the resection of the upper part of rectum in case of sigmoidectomy.

The issue of genito-urinary disorders after sigmoidectomy are poorly researched. Previous studies demonstrate a higher risk of erectile disorders after pelvic surgery and especially for cancer.

Currently, there is a lack of data on functional results and quality of life for patients who are going into sigmoid surgery, whether for cancer or diverticulitis. The aim of this longitudinal study is to compare digestive functional outcome, genitourinary outcomes and quality of life in patients who undergo sigmoid resection for diverticulitis and cancer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Sigmoidectomy for sigmoid cancerSigmoidectomySigmoid resection surgery for patients who suffer from sigmoid cancer
Sigmoidectomy for diverticulitisSigmoidectomySigmoid resection surgery for patients who suffer from symptomatic diverticulitis
Primary Outcome Measures
NameTimeMethod
LARS scoreAt the visit of twelve months

To measure incontinence troubles after low anterior resection. The score is from 0 to 42. The higher the score, the worst the incontinence.

Secondary Outcome Measures
NameTimeMethod
GIQLIAt the visit of twelve months

Quality of life related to gastrointestinal symptoms. Score from 0 to 144. The higher the score, the better the quality of life.

IIEF5At the visit of twelve months

Questionary about erection problems on patient's sex life. Score from 1 to 25. The higher the score, the better the sexual function.

Bristol stool chartAt the visit of twelve months

A scale to classify the form of the stools in seven category which indicate constipation or diarrhea in function of the type.

Types 1 and 2 indicate constipation, types 3 and 4 are normal stools, type 5, 6 and 7 indicate diarrhea.

ICIQ-FLUTSAt the visit of twelve months

Questionary for evaluating female lower urinary tract symptoms and impact on quality of life.

Score from 0 to 48. The higher the score, the worst the urinary continence.

SF-36At the visit of twelve months

General quality of life score. Described with 8 scaled scores, which are : vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, social role functioning, mental health.

Each scale score is from 0 to 100. The higher the score the less disability.

FSFIAt the visit of twelve months

Measure of sexual functioning in women. Score from 0 to 95. The higher the score, the better the sexual function.

IPSSAt the visit of twelve months

Questionary to screen and manage symptoms of benign prostatic hyperplasia. Score from 0 to 35. The higher the score, the worst the urinary function.

Trial Locations

Locations (4)

Vendée Departmental Hospital

🇫🇷

La Roche-sur-Yon, Vendée, France

Angers University Hospital

🇫🇷

Angers, Maine-et-Loire, France

Caen University Hospital

🇫🇷

Caen, Calvados, France

Nantes University Hospital

🇫🇷

Nantes, Loire-Atlantique, France

© Copyright 2025. All Rights Reserved by MedPath